2m 2m 2m 2m 2m 2m 2m
Stemtech (STEK)
OTC
$0.0001$0.00 (0.00%)
Price as of Jul 31, 2026- $237,195.00Market Cap
- -99.64%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Stemtech (STEK)
$0.0001$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.9M -43.08% | 5.1M +2.69% | 4.9M +7.94% | 4.6M +5.51% | |
Cost of Revenue | 566,940 -57.26% | 1.3M +32.42% | 1.0M -13.95% | 1.2M +13.77% | |
Gross Profit | 2.3M -38.04% | 3.7M -4.91% | 3.9M +15.45% | 3.4M +2.95% | |
Sales and Marketing Expense | 27,203 -72.57% | 99,178 -80.32% | 504,075 -5.50% | 533,397 -27.91% | |
Research and Development Expense | 0 N/A | N/A N/A | -13,800 N/A | N/A N/A | |
Depreciation and Amortization Expense | 167,495 -51.38% | 344,466 -41.40% | 587,797 +31.38% | 447,386 +4.39% | |
Total Operating Expenses | 5.0M -17.92% | 6.1M -24.93% | 8.1M -3.26% | 8.4M +29.35% | |
Operating Profit | -2.7M +13.52% | -2.4M -43.51% | -4.2M -15.90% | -5.0M +56.48% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -4.9M +19.41% | -4.1M -50.81% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -4.9M +19.41% | -4.1M -50.81% | |
Total Nonoperating Income and Expense | -1.3M -3.28% | -1.4M +14.81% | -1.2M -65.64% | -3.5M -9.92% | |
Income before Taxes | -4.0M +7.35% | -3.8M -30.55% | -5.4M -36.37% | -8.5M +20.05% | |
Income Taxes | 0 N/A | 0 N/A | 0 -100.00% | 95,618 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -4.0M +7.35% | -3.8M -30.52% | -5.4M -36.45% | -8.5M +20.73% | |
Net Income from Continuing Operations Applicable to Common | -4.0M +7.35% | -3.8M -30.55% | -5.4M -36.37% | -8.5M +20.05% | |
Basic EPS and Net Income | -0.02 -33.33% | -0.03 -57.14% | -0.07 -63.16% | -0.19 0.00% | |
Diluted EPS and Net Income | -0.02 -33.33% | -0.03 -57.14% | -0.07 -63.16% | -0.19 0.00% | |
Basic Weighted Average Shares | 169.8M +43.07% | 118.7M +42.20% | 83.5M +81.40% | 46.0M +22.33% | |
Diluted Weighted Average Shares | 169.8M +43.07% | 118.7M +42.20% | 83.5M +81.40% | 46.0M +22.33% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 238,245 -6.68% | 255,298 +123.62% | 114,166 -13.83% | 132,487 -84.00% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 238,245 -6.68% | 255,298 +123.62% | 114,166 -13.83% | 132,487 -84.00% | |
Total Current Assets | 457,062 -50.41% | 921,746 +130.03% | 400,710 -34.56% | 612,370 -61.73% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 0 N/A | 0 -100.00% | 10,056 N/A | N/A N/A | |
Total Long-Term Assets | 0 N/A | 0 -100.00% | 10,056 N/A | N/A N/A | |
Total Assets | 3.1M -16.73% | 3.8M +2.69% | 3.7M -13.68% | 4.3M -25.40% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 4.2M +9.08% | 3.8M +9.45% | 3.5M +275.22% | 929,131 -12.01% | |
Total Current Liabilities | 10.6M +17.52% | 9.0M +39.42% | 6.5M -12.86% | 7.4M -21.00% | |
Total Long-Term Debt | 0 N/A | 0 -100.00% | 15.6M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 0 N/A | 0 N/A | 0 -100.00% | 23,068 -93.19% | |
Total Liabilities | 10.6M +17.52% | 9.0M +39.42% | 6.5M -13.13% | 7.4M -23.51% | |
Retained Earnings | -34.9M +13.13% | -30.8M +13.93% | -27.1M +25.10% | -21.6M +65.30% | |
Total Stockholders Equity | -7.0M +55.18% | -4.5M +119.89% | -2.0M -16.22% | -2.4M -39.23% | |
Total Shares Outstanding | 426.0M +213.78% | 135.8M +29.31% | 105.0M +96.45% | 53.4M +19.60% | |
Cash Flow | |||||
Cash from Operating Activities | -483,583 -19.56% | -601,198 -70.47% | -2.0M +67.30% | -1.2M -36.42% | |
Capital Expenditures | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 460,010 -57.37% | 1.1M -31.68% | 1.6M +366.27% | 338,734 -87.11% | |
Financials Ratio | |||||
Gross Margin | 80.29% +8.86% | 73.75% -7.40% | 79.65% +6.95% | 74.47% -2.43% | |
Operating Margin | -94.18% +99.45% | -47.22% -44.99% | -85.84% -22.09% | -110.18% +48.31% | |
Return on Assets | -116.85% +15.61% | -101.07% -26.01% | -136.61% -20.17% | -171.12% -30.29% | |
Return on Equity | 70.78% -38.80% | 115.67% -52.36% | 242.78% -8.52% | 265.39% -20.67% | |
Revenue Growth | -43.08% -1,704.42% | 2.69% -66.19% | 7.94% +44.12% | 5.51% N/A | |
Current Ratio | 0.04 -57.77% | 0.10 +65.00% | 0.06 -24.94% | 0.08 -51.55% | |
Cash Ratio | 0.02 -20.49% | 0.03 +59.89% | 0.02 -1.12% | 0.02 -79.71% | |
Debt-to-Equity Ratio | -0.60 -29.71% | -0.85 -90.92% | -9.38 +2,356.41% | -0.38 +19.88% | |
Debt-to-Assets Ratio | 1.32 +31.00% | 1.01 -80.57% | 5.19 +2,283.43% | 0.22 -2.33% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow